Survival After Surviving -- Estimating Late Recurrence Risk
How does recurrence risk change for a patient who has already survived ovarian cancer for a few years? Maurie Markman comments on a recent Journal of Clinical Oncology paper addressing the question. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - March 13, 2015 Category: OBGYN Authors: Medscape Source Type: podcasts
Survival After Surviving -- Estimating Late Recurrence Risk
How does recurrence risk change for a patient who has already survived ovarian cancer for a few years? Maurie Markman comments on a recent Journal of Clinical Oncology paper addressing the question. (Source: Medscape Oncology)
Source: Medscape Oncology - March 13, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
How to Prevent Ovarian Cancer
The fallopian tubes may be the answer to the puzzle of ovarian cancer pathogenesis. Dr Lundberg explains. (Source: Medscape Internal Medicine Podcast)
Source: Medscape Internal Medicine Podcast - March 6, 2015 Category: Internal Medicine Authors: Medscape Source Type: podcasts
Prof Jonathan Ledermann at ESMO 2014: Inhibiting PARP, angiogenesis and immune checkpoints for treating ovarian cancer
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Jonathan Ledermann (University College London, UK) discusses recent advances in the management of ovarian cancer, including the ...
Author: EMJ
Added: 03/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 5, 2015 Category: Cancer & Oncology Source Type: podcasts
Prof Jonathan Ledermann at ESMO 2014: Inhibiting PARP, angiogenesis and immune checkpoints for ovarian cancer treatment
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Jonathan Ledermann (University College London, UK) discusses recent advances in the management of ovarian cancer, including the ...
Author: EMJ
Added: 03/05/2015 (Source: Oncology Tube)
Source: Oncology Tube - March 5, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr. Francis on Ovarian Suppression for Younger Women With HR+ Breast Cancer
Dr. Francis' discusses the SOFT trial, which examined ovarian function, and the impact it could have on the future treatment of women under 35 with hormone receptor-positive breast cancer.
Prudence F...
Author: feeds
Added: 02/23/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 23, 2015 Category: Cancer & Oncology Source Type: podcasts
Molecular profiling of chemoresistant ovarian tumors: discussion with Dr. Martina Bazzaro on changes at the cellular level
This is my discussion with Martina Bazzaro, Ph.D, researcher in the Division of Gynecologic Oncology at the University of Minnesota. Here, she shares information on how she and her research team obtai...
Author: cancerassassin1
Added: 01/19/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2015 Category: Cancer & Oncology Source Type: podcasts
Mouse Avatars: Discussion with Dr. Timothy Starr on the Road to Personalized Medicine in Ovarian Cancer
This is my discussion with Tim Starr, Ph.D, a cancer researcher in the Division of Gynecologic Oncology at the University of MInnesota (med.umn.edu/starrlab/).
Our topic of conversation in this seg...
Author: cancerassassin1
Added: 01/16/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 16, 2015 Category: Cancer & Oncology Source Type: podcasts
Dr Susan Galbraith at ESMO 2014: Phase II Study 19 quality of life study of olaparib in ovarian cancer
At the European Society for Medical Oncology (ESMO) 2014 Congress, Dr Susan Galbraith (Vice-President Oncology, AstraZeneca) discusses the Study 19 phase II quality of life study of maintenance treatm...
Author: EMJ
Added: 01/15/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2015 Category: Cancer & Oncology Source Type: podcasts
Ovarian Cancer: Interview with Dr. Elizabeth Dickson, Gynecologist Oncologist on studying chemotherapy-resistant ovarian cancer at the cellular level
This is a short interview with Dr. Elizabeth Dickson, Gynecologic Oncologist, on her work in my lab. Dr. Dickson studied the potential role of cellular communication in development of platinum chemoth...
Author: cancerassassin1
Added: 12/30/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 30, 2014 Category: Cancer & Oncology Source Type: podcasts
SOFT Yields Hard Data on Hormone Therapy
Drs Kathy Miller and Ann Partridge drill down on the practice-changing data from the SOFT trial, indicating which breast cancer patients should receive ovarian suppression. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
SABCS 2014: SOFT Trial Commentary by Dr. Sunil Verma
: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone recep...
Author: oncologyeducation
Added: 12/11/2014 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2014 Category: Cancer & Oncology Source Type: podcasts
Heart Health: Links to Pregnancy and Delivery
Factors that affect a woman's reproductive health can also have an effect on her heart, new research shows. Giving birth prematurely or delivering a small-for-gestational-age baby is associated with a later risk of cardiovascular disease in the mother. Another study found that when women's ovaries were removed and the estrogen was not replaced through hormone therapy, a woman's overall risk of dying increased, as did her risk of dying of heart disease or stroke. (Source: MUSC Heart and Vascular Podcast)
Source: MUSC Heart and Vascular Podcast - December 3, 2014 Category: Cardiology Authors: Medical University of South Carolina Source Type: podcasts
The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian Cancer
Dr. Bradley Monk discusses the novel PARP inhibitors (PARPi) in clinical development for advanced ovarian cancers and provides the clinical context for their integration into existing treatment paradi...
Author: imedex
Added: 11/30/2014 (Source: Oncology Tube)
Source: Oncology Tube - November 30, 2014 Category: Cancer & Oncology Source Type: podcasts
Too Soon for Broad BRCA Screening
Dr Maurie Markman discusses the controversy surrounding routine BRCA screening for breast and ovarian cancer and suggests that it is too soon for widespread genetic screening. (Source: Medscape Oncology)
Source: Medscape Oncology - October 7, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
